Celloid
Celloid provides the optimum 3D cell culture medium, allowing the quality-controlled long-term cultivation of organoids.
Celloid operates in biopharma, biotechnology, medical based in Asia-Pacific (APAC), founded in 2021.
Celloid is positioned in biopharma, biotechnology, medical, a segment that rewards a clear, focused offering.
Its base of operations is Asia-Pacific (APAC).
Directory data places it at the Seed stage.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $2.4B in funding.
| Sector | Biopharma, Biotechnology, Medical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2021 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $2,400,000,000 |
Website: celloid.co.kr
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account